Ascletis Pharma, Inc.(HK:1672)
HK$4.70-0.14 (-3.00%)
HK:1672
Ascletis Pharma, Inc. financials statements
HK$4.70
At close:-0.14 (-3.00%)
Want to see HK:1672 full AI Analyst Report?
Ascletis Pharma, Inc. (1672) Income Statement
9 Followers
Ascletis Pharma, Inc. Income Statement
Last quarter (Q2 2026), Ascletis Pharma, Inc.'s total revenue was ¥0.00. In Q2, Ascletis Pharma, Inc.'s net income was ¥-320.03M. See Ascletis Pharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 2.03M | ¥ 1.28M | ¥ 56.60M | ¥ 54.09M | ¥ 76.88M | |
| ¥ 527.00K | ¥ 735.00K | ¥ 25.99M | ¥ -24.69M | ¥ 39.17M | |
| ¥ 484.29M | ¥ 296.15M | ¥ 150.29M | ¥ 319.29M | ¥ 264.14M | |
| Depreciation and Amortization | ¥ 17.62M | ¥ 20.45M | ¥ 18.48M | ¥ 30.19M | ¥ 29.55M |
| ¥ -466.92M | ¥ -384.18M | ¥ -126.09M | ¥ -284.50M | ¥ -169.35M | |
| ¥ -483.76M | ¥ -295.42M | ¥ -300.21M | ¥ -343.98M | ¥ -224.97M | |
| ¥ 124.38M | ¥ -5.52M | ¥ 155.49M | ¥ 29.13M | ¥ 25.95M | |
| ¥ -359.37M | ¥ -300.94M | ¥ -144.72M | ¥ -314.84M | ¥ -199.02M | |
| ¥ -359.88M | ¥ -300.94M | ¥ -144.72M | ¥ -314.84M | ¥ -199.02M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -0.37 | ¥ -0.30 | ¥ -0.13 | ¥ -0.29 | ¥ -0.18 |
| Diluted EPS | ¥ -0.37 | ¥ -0.30 | ¥ -0.13 | ¥ -0.29 | ¥ -0.18 |
| Weighted Average Shares Outstanding | 972.51M | 1.00B | 1.07B | 1.09B | 1.10B |
| Weighted Average Shares Outstanding (Diluted) | 972.51M | 1.00B | 1.07B | 1.09B | 1.10B |
Currency in CNY
